The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
| Autor: | M A Frolova |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2016 |
| Předmět: | |
| Zdroj: | Современная онкология, Vol 18, Iss 3, Pp 33-37 (2016) |
| Druh dokumentu: | article |
| ISSN: | 1815-1434 1815-1442 |
| Popis: | Nab-paclitaxel is nanoparticle albumin-bound paclitaxel. Nab-paclitaxel is free from any kind of solvent and thus reduces the risk of hypersensitivity reactions and other side effects, compared with standard taxanes (paclitaxel, docetaxel). There is no need to use premedication with glucocorticoids and antihistamines during nab-paclitaxel application. In addition, several studies have demonstrated that nab-paclitaxel allows achieving a higher drug concentration in tumor. The article deals with the basic studies of nab-paclitaxel application using different doses and introduction regimens in patients with metastatic breast cancer. We show the algorithm for optimal use of nab-paclitaxel in different clinical cases. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|